| Galectin-3 in Heart Failure An Update of the Last 3 Years |
18 |
| Ultrasound of the Lungs More than a Room with a View |
17 |
| Diabetic Cardiomyopathy Definition, Diagnosis, and Therapeutic Implications |
17 |
| Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy |
16 |
| Soluble ST2 in Heart Failure |
15 |
| Natriuretic Peptides in Heart Failure Atrial and B-type Natriuretic Peptides |
13 |
| Heart Failure with Reduced Ejection Fraction in Women Epidemiology, Outcomes, and Treatment |
12 |
| Metabolic Biomarkers in Heart Failure |
10 |
| Hypertension and Heart Failure |
9 |
| Adrenomedullin as a Biomarker of Heart Failure |
8 |
| Hypertension and Arrhythmias |
8 |
| Stress-Induced Cardiomyopathy |
7 |
| Pulmonary Arterial Hypertension |
7 |
| Right Heart Catheterization for the Diagnosis of Pulmonary Hypertension Controversies and Practical Issues |
7 |
| Hypertensive Heart Disease and Obesity A Review |
7 |
| N-Terminal B-type Natriuretic Peptide in Heart Failure |
6 |
| Clinical Presentation and Natural History of Hypertrophic Cardiomyopathy in RASopathies |
6 |
| Heart Failure with Preserved Ejection Fraction in Women |
5 |
| Epidemiology and Clinical Aspects of Genetic Cardiomyopathies |
5 |
| The Evolution from Hypertension to Heart Failure |
5 |
| Diagnostic Criteria, Genetics, and Molecular Basis of Arrhythmogenic Cardiomyopathy |
5 |
| beta-Adrenergic Receptor Signaling and Heart Failure: From Bench to Bedside |
4 |
| Right Heart-Pulmonary Circulation Unit in Congenital Heart Diseases |
4 |
| Metabolic Syndrome in Heart Failure: Friend or Foe? |
4 |
| Anemia and Iron Deficiency in Heart Failure Clinical and Prognostic Role |
4 |
| Sex-Specific Differences in Risk Factors for Development of Heart Failure in Women |
4 |
| The Role of Echocardiography in Heart Failure with Preserved Ejection Fraction What Do We Want from Imaging? |
4 |
| Advanced Therapies for Advanced Heart Failure in Women |
4 |
| Biomarkers and Imaging Complementary or Subtractive? |
4 |
| Valvular Heart Disease and Heart Failure in Women |
3 |
| Right Ventricular Size and Function in Chronic Heart Failure: Not to Be Forgotten |
3 |
| Growth Hormone Therapy in Heart Failure |
3 |
| Current Status of Inotropes in Heart Failure |
3 |
| Short-Term Circulatory and Right Ventricle Support in Cardiogenic Shock Extracorporeal Membrane Oxygenation, Tandem Heart, CentriMag, and Impella |
3 |
| Management of Heart Failure in Adult Congenital Heart Disease |
3 |
| Mitral Valve Surgery for Congestive Heart Failure |
3 |
| Acromegaly and Heart Failure |
3 |
| Heart Failure in Women Due to Hypertensive Heart Disease |
3 |
| Heart Failure and Changes in Kidney Function Focus on Understanding, Not Reacting |
3 |
| Pulmonary Hypertension The Role of Lung Transplantation |
3 |
| Pulmonary Hypertension and Heart Failure A Dangerous Liaison |
3 |
| Genetic Testing for Cardiomyopathies in Clinical Practice |
3 |
| Proteomic Biomarkers of Heart Failure |
3 |
| The Right Heart-Pulmonary Circulation Unit in Systemic Hypertension |
2 |
| The Right Heart-Pulmonary Circulation Unit Physiopathology |
2 |
| Exercise Training and Rehabilitation in Pulmonary Hypertension |
2 |
| Glucose Metabolism Abnormalities in Heart Failure Patients Insights and Prognostic Relevance |
2 |
| The Right Heart International Network (RIGHT-NET) Rationale, Objectives, Methodology, and Clinical Implications |
2 |
| Hormonal Replacement Therapy in Heart Failure Focus on Growth Hormone and Testosterone |
2 |
| The Management of Thyroid Abnormalities in Chronic Heart Failure |
2 |
